SMTL ID : 2pw1.1

Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWNSL

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

hetero-oligomer

Ligands

1 x GLU- LEU- ASP- LYS- TRP- ASN- SER- LEU: peptide epitope(Non-covalent)

GLU-LEU-ASP-LYS-TRP-ASN-SER-LEU.1: 14 residues within 4Å: Chain A: L.91, H.92, F.93, Y.94, H.96 Chain B: G.33, Y.54, D.56, D.58, R.60, R.100, P.103, R.113, V.116 19 PLIP interactions: 13 interactions with chain B, 6 interactions with chain A Hydrophobic interactions: B:Y.54, B:P.103, B:R.113, B:V.116, A:F.93 Hydrogen bonds: B:D.56, B:D.58, B:R.113, A:H.92, A:Y.94, A:Y.94 Water bridges: B:R.60, B:R.100, B:R.113, A:L.91 Salt bridges: B:R.60, B:R.100, B:R.113, A:H.96

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bryson, S. et al., Crystallographic definition of the epitope promiscuity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5: vaccine design implications. J.Virol. (2009)

Release Date

2007-05-22

Peptides

2F5 Fab fragment heavy chain: A
2F5 Fab fragment light chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

2F5 Fab fragment heavy chain

2F5 Fab fragment light chain

Related Entries With Identical Sequence